Ascendis Pharma A/S - SPONSORED ADR (ASND)

Historical Portfolio Holders from Q1 2015 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q1 2024
60.4 M
Holdings value Q1 2024
$9.13 B
Value change Q1 2024
+$188 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
180
Number of buys Q1 2024
107
Number of sells Q1 2024
-79
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.002%
CUSIP
04351P101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 60.4 M $9.13 B +$188 M $151.17 180
2023 Q4 60 M $7.56 B -$118 M $125.95 180
2023 Q3 60.3 M $5.64 B -$73.7 M $93.64 159
2023 Q2 61 M $5.44 B -$43.6 M $89.25 158
2023 Q1 61 M $6.53 B -$599 M $107.22 160
2022 Q4 65.7 M $8.02 B -$71.1 M $122.13 179
2022 Q3 66.3 M $6.85 B +$156 M $103.26 171
2022 Q2 63.1 M $5.86 B +$102 M $92.96 161
2022 Q1 61.9 M $7.26 B +$414 M $117.36 170
2021 Q4 58.3 M $7.85 B -$60.4 M $134.53 166
2021 Q3 58 M $9.24 B +$506 M $159.39 167
2021 Q2 55 M $7.24 B +$272 M $131.55 170
2021 Q1 52.6 M $6.79 B -$267 M $128.88 171
2020 Q4 54.1 M $9.02 B +$127 M $166.78 169
2020 Q3 53.3 M $8.23 B +$764 M $154.32 148
2020 Q2 48.2 M $7.13 B +$38.8 M $147.90 150
2020 Q1 47.9 M $5.39 B +$191 M $112.61 140
2019 Q4 46.1 M $6.42 B -$13.1 M $139.12 140
2019 Q3 46.1 M $4.44 B -$194 M $96.32 126
2019 Q2 47.7 M $5.49 B +$238 M $115.15 133
2019 Q1 46 M $5.41 B +$712 M $117.70 139
2018 Q4 40.1 M $2.51 B -$10.8 M $62.65 103
2018 Q3 40.2 M $2.85 B +$44.5 M $70.86 94
2018 Q2 39.6 M $2.63 B +$96.2 M $66.52 98
2018 Q1 38.1 M $2.49 B +$345 M $65.40 89
2017 Q4 30.5 M $1.22 B +$52.9 M $40.06 64
2017 Q3 28.8 M $1.04 B +$201 M $36.25 59
2017 Q2 23.3 M $646 M +$76.1 M $27.76 34
2017 Q1 20.9 M $585 M +$9.05 M $28.00 34
2016 Q4 20.6 M $416 M +$131 M $20.24 30
2016 Q3 14 M $281 M +$4.79 M $20.10 22
2016 Q2 13.9 M $184 M +$10.2 M $13.27 23
2016 Q1 12 M $223 M +$9.84 M $18.55 25
2015 Q4 10.1 M $185 M +$3.82 M $18.32 24
2015 Q3 7.46 M $132 M +$7.98 M $17.70 23
2015 Q2 8.95 M $158 M -$8 M $17.68 31
2015 Q1 7.45 M $128 M +$128 M $17.35 34